CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: benzothiadiazole
Accession: CHEBI:48864
browse the term
Synonyms: related_synonym: benzothiadiazoles
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
affects metabolic processing increases metabolic processing multiple interactions
ISO
CYP1A2 protein affects the metabolism of tizanidine CYP1A2 protein results in increased metabolism of tizanidine [[Ethinyl Estradiol co-treated with Gestodene] results in decreased activity of CYP1A2 protein] which results in decreased metabolism of tizanidine; Ciprofloxacin inhibits the reaction [CYP1A2 protein affects the metabolism of tizanidine]; rofecoxib inhibits the reaction [CYP1A2 protein results in increased metabolism of tizanidine]
CTD
PMID:15592331 PMID:15834531 PMID:16198659 PMID:16934051 PMID:17618427
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
A2m
alpha-2-macroglobulin
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of A2M mRNA
CTD
PMID:27935865
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
G
Abca8
ATP binding cassette subfamily A member 8
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ABCA8B mRNA
CTD
PMID:27935865
NCBI chr10:94,917,520...94,991,199
Ensembl chr10:94,917,520...94,990,988
G
Abhd14b
abhydrolase domain containing 14b
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of ABHD14B mRNA]
CTD
PMID:29891994
NCBI chr 8:107,087,157...107,092,122
Ensembl chr 8:107,088,069...107,092,119
G
Acod1
aconitate decarboxylase 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of ACOD1 mRNA
CTD
PMID:27935865
NCBI chr15:79,871,819...79,881,101
Ensembl chr15:79,871,827...79,880,529
G
Acta2
actin alpha 2, smooth muscle
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of ACTA2 mRNA]
CTD
PMID:29891994
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
G
Actg2
actin gamma 2, smooth muscle
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ACTG2 mRNA
CTD
PMID:27935865
NCBI chr 4:116,021,832...116,046,475
Ensembl chr 4:116,021,832...116,046,465
G
Adam8
ADAM metallopeptidase domain 8
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of ADAM8 mRNA
CTD
PMID:27935865
NCBI chr 1:194,776,559...194,789,330
Ensembl chr 1:194,770,060...194,788,801
G
Adcy5
adenylate cyclase 5
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ADCY5 mRNA
CTD
PMID:27935865
NCBI chr11:65,471,612...65,618,877
Ensembl chr11:65,471,612...65,618,974
G
Adcyap1r1
ADCYAP receptor type I
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ADCYAP1R1 mRNA
CTD
PMID:27935865
NCBI chr 4:84,593,558...84,642,700
Ensembl chr 4:84,593,892...84,642,700
G
Adgra2
adhesion G protein-coupled receptor A2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ADGRA2 mRNA
CTD
PMID:27935865
NCBI chr16:64,932,964...64,971,433
Ensembl chr16:64,933,315...64,971,483
G
Adgrg3
adhesion G protein-coupled receptor G3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of ADGRG3 mRNA
CTD
PMID:27935865
NCBI chr19:9,972,425...10,001,118
Ensembl chr19:9,972,430...10,001,123
G
Adipoq
adiponectin, C1Q and collagen domain containing
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ADIPOQ mRNA
CTD
PMID:27935865
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
G
Adora1
adenosine A1 receptor
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ADORA1 mRNA
CTD
PMID:27935865
NCBI chr13:45,658,872...45,695,821
Ensembl chr13:45,658,872...45,695,801
G
Agbl1
AGBL carboxypeptidase 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of AGBL1 mRNA
CTD
PMID:27935865
NCBI chr 1:130,043,914...130,950,739
Ensembl chr 1:130,043,970...130,951,638
G
Agtr2
angiotensin II receptor, type 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of AGTR2 mRNA
CTD
PMID:27935865
NCBI chr X:112,119,876...112,124,060
Ensembl chr X:112,120,228...112,124,057
G
Akr1d1
aldo-keto reductase family 1, member D1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of AKR1D1 mRNA
CTD
PMID:27935865
NCBI chr 4:66,154,246...66,187,505
Ensembl chr 4:66,154,248...66,186,372
G
Ambp
alpha-1-microglobulin/bikunin precursor
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of AMBP mRNA
CTD
PMID:27935865
NCBI chr 5:76,568,094...76,578,416
Ensembl chr 5:76,568,094...76,578,331
G
Aoc3
amine oxidase, copper containing 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of AOC3 mRNA
CTD
PMID:27935865
NCBI chr10:86,272,757...86,280,702
G
Apoc2
apolipoprotein C2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of APOC2 mRNA
CTD
PMID:27935865
NCBI chr 1:79,329,429...79,334,397
Ensembl chr 1:79,329,428...79,334,476
G
Arhgap36
Rho GTPase activating protein 36
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ARHGAP36 mRNA
CTD
PMID:27935865
NCBI chr X:128,780,148...128,787,169
Ensembl chr X:128,751,900...128,787,161
G
Arhgef19
Rho guanine nucleotide exchange factor 19
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of ARHGEF19 mRNA]
CTD
PMID:29891994
NCBI chr 5:153,536,038...153,554,203
Ensembl chr 5:153,536,013...153,554,203
G
Armcx6
armadillo repeat containing, X-linked 6
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of ARMCX6 mRNA]
CTD
PMID:29891994
NCBI chr X:97,929,032...97,932,031
Ensembl chr X:97,929,041...97,931,977
G
Asb10
ankyrin repeat and SOCS box-containing 10
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ASB10 mRNA
CTD
PMID:27935865
NCBI chr 4:10,630,318...10,644,270
Ensembl chr 4:10,630,448...10,639,060
G
Asb13
ankyrin repeat and SOCS box-containing 13
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of ASB13 mRNA]
CTD
PMID:29891994
NCBI chr17:66,564,653...66,583,365
Ensembl chr17:66,562,434...66,583,337
G
Asb16
ankyrin repeat and SOCS box-containing 16
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ASB16 mRNA
CTD
PMID:27935865
NCBI chr10:87,225,976...87,233,078
Ensembl chr10:87,225,912...87,233,078
G
Ascl2
achaete-scute family bHLH transcription factor 2
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of ASCL2 mRNA]
CTD
PMID:29891994
NCBI chr 1:198,148,999...198,151,406
Ensembl chr 1:198,148,999...198,151,406
G
Atp1a2
ATPase Na+/K+ transporting subunit alpha 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ATP1A2 mRNA
CTD
PMID:27935865
NCBI chr13:84,729,597...84,754,544
Ensembl chr13:84,729,601...84,754,544
G
Atp1a3
ATPase Na+/K+ transporting subunit alpha 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of ATP1A3 mRNA
CTD
PMID:27935865
NCBI chr 1:80,572,790...80,601,936
Ensembl chr 1:80,572,796...80,601,918
G
Avpr1a
arginine vasopressin receptor 1A
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of AVPR1A mRNA
CTD
PMID:27935865
NCBI chr 7:58,114,306...58,118,230
Ensembl chr 7:58,114,284...58,122,215
G
B4galnt2
beta-1,4-N-acetyl-galactosaminyl transferase 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of B4GALNT2 mRNA
CTD
PMID:27935865
NCBI chr10:80,801,594...80,828,005
Ensembl chr10:80,802,941...80,857,700
G
Bend4
BEN domain containing 4
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of BEND4 mRNA
CTD
PMID:27935865
NCBI chr14:40,753,048...40,788,686
Ensembl chr14:40,753,077...40,783,504
G
Bhlha15
basic helix-loop-helix family, member a15
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of BHLHA15 mRNA
CTD
PMID:27935865
NCBI chr12:10,420,465...10,424,641
Ensembl chr12:10,420,467...10,424,713
G
Bpifa5
BPI fold containing family A, member 5
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of BPIFA5 mRNA
CTD
PMID:27935865
NCBI chr 3:142,646,103...142,652,884
Ensembl chr 3:142,646,103...142,652,883
G
Bpifb1
BPI fold containing family B, member 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of BPIFB1 mRNA
CTD
PMID:27935865
NCBI chr 3:142,672,995...142,706,258
Ensembl chr 3:142,672,995...142,706,256
G
Bricd5
BRICHOS domain containing 5
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of BRICD5 mRNA
CTD
PMID:27935865
NCBI chr10:13,498,726...13,500,259
Ensembl chr10:13,498,381...13,500,259
G
Btn1a1
butyrophilin, subfamily 1, member A1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of BTN1A1 mRNA
CTD
PMID:27935865
NCBI chr17:41,653,499...41,664,246
Ensembl chr17:41,654,249...41,664,272
G
C1qtnf2
C1q and TNF related 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of C1QTNF2 mRNA
CTD
PMID:27935865
NCBI chr10:27,941,948...27,958,926
Ensembl chr10:27,941,948...27,959,185
G
C1qtnf7
C1q and TNF related 7
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of C1QTNF7 mRNA
CTD
PMID:27935865
NCBI chr14:67,467,888...67,580,477
Ensembl chr14:67,468,014...67,580,410
G
C5ar1
complement C5a receptor 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of C5AR1 mRNA
CTD
PMID:27935865
NCBI chr 1:76,948,622...76,959,826
G
C5ar2
complement C5a receptor 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of C5AR2 mRNA
CTD
PMID:27935865
NCBI chr 1:76,930,381...76,945,432
Ensembl chr 1:76,930,383...76,959,517
G
Camk2n1
calcium/calmodulin-dependent protein kinase II inhibitor 1
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of CAMK2N1 mRNA]
CTD
PMID:29891994
NCBI chr 5:150,674,819...150,676,600
Ensembl chr 5:150,673,507...150,676,600
G
Car3
carbonic anhydrase 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CAR3 mRNA
CTD
PMID:27935865
NCBI chr 2:86,770,418...86,780,011
Ensembl chr 2:86,770,420...86,784,280
G
Card10
caspase recruitment domain family, member 10
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of CARD10 mRNA]
CTD
PMID:29891994
NCBI chr 7:110,330,460...110,371,551
Ensembl chr 7:110,330,408...110,359,224
G
Cbx4
chromobox 4
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of CBX4 mRNA]
CTD
PMID:29891994
NCBI chr10:104,337,140...104,343,210
Ensembl chr10:104,336,876...104,356,706
G
Ccdc42
coiled-coil domain containing 42
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CCDC42 mRNA
CTD
PMID:27935865
NCBI chr10:53,289,956...53,300,135
Ensembl chr10:53,289,956...53,300,135
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CCL2 mRNA
CTD
PMID:27935865
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl3
C-C motif chemokine ligand 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CCL3 mRNA
CTD
PMID:27935865
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
G
Ccl7
C-C motif chemokine ligand 7
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CCL7 mRNA
CTD
PMID:27935865
NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
G
Ccna1
cyclin A1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CCNA1 mRNA; XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of CCNA1 mRNA]
CTD
PMID:27935865 PMID:29891994
NCBI chr 2:139,231,738...139,278,066
Ensembl chr 2:139,201,074...139,243,157
G
Ccno
cyclin O
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CCNO mRNA
CTD
PMID:27935865
NCBI chr 2:44,630,873...44,633,912
Ensembl chr 2:44,626,369...44,633,914
G
Cd177
CD177 molecule
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CD177 mRNA
CTD
PMID:27935865
NCBI chr 1:80,340,034...80,360,599
Ensembl chr 1:80,340,034...80,360,621
G
Cd5l
Cd5 molecule-like
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CD5L mRNA
CTD
PMID:27935865
NCBI chr 2:172,791,007...172,802,018
Ensembl chr 2:172,790,934...172,829,753
G
Cdc20b
cell division cycle 20B
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CDC20B mRNA
CTD
PMID:27935865
NCBI chr 2:44,688,349...44,738,056
G
Cdh26
cadherin 26
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CDH26 mRNA
CTD
PMID:27935865
NCBI chr 3:165,520,523...165,573,191
Ensembl chr 3:165,520,439...165,572,149
G
Cdhr1
cadherin-related family member 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CDHR1 mRNA
CTD
PMID:27935865
NCBI chr16:12,843,436...12,863,321
Ensembl chr16:12,843,437...12,863,396
G
Celsr3
cadherin, EGF LAG seven-pass G-type receptor 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CELSR3 mRNA
CTD
PMID:27935865
NCBI chr 8:109,530,597...109,558,360
Ensembl chr 8:109,530,641...109,558,354
G
Cfd
complement factor D
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CFD mRNA
CTD
PMID:27935865
NCBI chr 7:9,813,148...9,814,871
Ensembl chr 7:9,813,150...9,815,053
G
Chi3l1
chitinase 3 like 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CHI3L1 mRNA
CTD
PMID:27935865
NCBI chr13:45,641,802...45,649,787
Ensembl chr13:45,641,802...45,649,787
G
Chodl
chondrolectin
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CHODL mRNA
CTD
PMID:27935865
NCBI chr11:17,654,137...17,676,450
Ensembl chr11:17,654,206...17,676,441
G
Chrdl1
chordin-like 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CHRDL1 mRNA
CTD
PMID:27935865
NCBI chr X:106,889,125...106,992,937
Ensembl chr X:106,889,125...106,992,921
G
Chrm2
cholinergic receptor, muscarinic 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CHRM2 mRNA
CTD
PMID:27935865
NCBI chr 4:65,015,408...65,149,104
Ensembl chr 4:65,014,144...65,149,103
G
Chst5
carbohydrate sulfotransferase 5
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CHST5 mRNA
CTD
PMID:27935865
NCBI chr19:39,860,729...39,881,019
Ensembl chr19:39,860,501...39,881,064
G
Cidec
cell death-inducing DFFA-like effector c
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CIDEC mRNA
CTD
PMID:27935865
NCBI chr 4:146,569,288...146,582,173
Ensembl chr 4:146,569,289...146,582,173
G
Ckmt2
creatine kinase, mitochondrial 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CKMT2 mRNA
CTD
PMID:27935865
NCBI chr 2:23,079,918...23,110,518
Ensembl chr 2:23,079,918...23,110,430
G
Clec4d
C-type lectin domain family 4, member D
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CLEC4D mRNA
CTD
PMID:27935865
NCBI chr 4:156,589,591...156,599,279
Ensembl chr 4:156,589,792...156,598,848
G
Clec4e
C-type lectin domain family 4, member E
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CLEC4E mRNA
CTD
PMID:27935865
NCBI chr 4:156,606,927...156,612,911
Ensembl chr 4:156,607,614...156,612,767
G
Cnn1
calponin 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CNN1 mRNA
CTD
PMID:27935865
NCBI chr 8:20,632,434...20,641,097
Ensembl chr 8:20,632,338...20,641,098
G
Cntfr
ciliary neurotrophic factor receptor
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CNTFR mRNA
CTD
PMID:27935865
NCBI chr 5:56,823,448...56,861,049
Ensembl chr 5:56,823,965...56,841,392
G
Colq
collagen like tail subunit of asymmetric acetylcholinesterase
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of COLQ mRNA
CTD
PMID:27935865
NCBI chr16:6,731,850...6,824,973
Ensembl chr16:6,731,858...6,787,107
G
Cox7a1
cytochrome c oxidase subunit 7A1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of COX7A1 mRNA
CTD
PMID:27935865
NCBI chr 1:85,422,162...85,447,530
Ensembl chr 1:85,441,871...85,445,151
G
Cplx1
complexin 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CPLX1 mRNA
CTD
PMID:27935865
NCBI chr14:1,184,677...1,216,392
G
Creb1
cAMP responsive element binding protein 1
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of CREB1 mRNA]
CTD
PMID:29891994
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
G
Creb3l3
cAMP responsive element binding protein 3-like 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CREB3L3 mRNA
CTD
PMID:27935865
NCBI chr 7:8,622,614...8,631,053
Ensembl chr 7:8,622,614...8,631,048
G
Crisp3
cysteine-rich secretory protein 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CRISP3 mRNA
CTD
PMID:27935865
NCBI chr 9:20,432,051...20,472,663
Ensembl chr 9:20,450,908...20,472,658
G
Crispld1
cysteine-rich secretory protein LCCL domain containing 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CRISPLD1 mRNA
CTD
PMID:27935865
NCBI chr 5:1,267,347...1,314,926
Ensembl chr 5:1,274,647...1,314,926
G
Cryl1
crystallin, lambda 1
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of CRYL1 mRNA]
CTD
PMID:29891994
NCBI chr15:31,427,011...31,545,997
Ensembl chr15:31,427,054...31,545,997
G
Csf3
colony stimulating factor 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CSF3 mRNA
CTD
PMID:27935865
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
G
Csf3r
colony stimulating factor 3 receptor
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CSF3R mRNA
CTD
PMID:27935865
NCBI chr 5:138,298,605...138,318,224
Ensembl chr 5:138,301,506...138,317,881
G
Csrp1
cysteine and glycine-rich protein 1
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of CSRP1 mRNA]
CTD
PMID:29891994
NCBI chr13:47,158,171...47,179,388
Ensembl chr13:47,167,789...47,179,384
G
Ctsc
cathepsin C
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of CTSC mRNA]
CTD
PMID:29891994
NCBI chr 1:142,028,386...142,059,841
Ensembl chr 1:142,028,392...142,060,387
G
Cxcl12
C-X-C motif chemokine ligand 12
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CXCL12 mRNA
CTD
PMID:27935865
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
G
Cxcl2
C-X-C motif chemokine ligand 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CXCL2 mRNA
CTD
PMID:27935865
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
G
Cxcl3
C-X-C motif chemokine ligand 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CXCL3 mRNA
CTD
PMID:27935865
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
G
Cxcl6
C-X-C motif chemokine ligand 6
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CXCL5 mRNA
CTD
PMID:27935865
NCBI chr14:17,310,790...17,312,250
Ensembl chr14:17,310,426...17,313,093
G
Cxcr2
C-X-C motif chemokine receptor 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CXCR2 mRNA
CTD
PMID:27935865
NCBI chr 9:75,729,493...75,735,868
Ensembl chr 9:75,729,115...75,739,425
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CYP2E1 mRNA
CTD
PMID:27935865
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Cyp4f18
cytochrome P450, family 4, subfamily f, polypeptide 18
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CYP4F18 mRNA
CTD
PMID:27935865
NCBI chr16:17,763,543...17,804,944
Ensembl chr16:17,707,317...17,804,940
G
Cys1
cystin 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CYS1 mRNA
CTD
PMID:27935865
NCBI chr 6:41,300,836...41,318,071
Ensembl chr 6:41,300,836...41,318,071
G
Dcaf12l1
DDB1 and CUL4 associated factor 12-like 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of DCAF12L1 mRNA
CTD
PMID:27935865
NCBI chr X:123,695,286...123,698,905
Ensembl chr X:123,695,286...123,698,905
G
Dchs1
dachsous cadherin-related 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of DCHS1 mRNA
CTD
PMID:27935865
NCBI chr 1:160,104,931...160,138,958
Ensembl chr 1:160,104,931...160,124,808
G
Degs2
delta(4)-desaturase, sphingolipid 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of DEGS2 mRNA
CTD
PMID:27935865
NCBI chr 6:127,596,063...127,613,293
Ensembl chr 6:127,596,071...127,613,293
G
Derl3
derlin 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of DERL3 mRNA
CTD
PMID:27935865
NCBI chr20:12,754,490...12,768,454
Ensembl chr20:12,763,543...12,767,027
G
Dhdh
dihydrodiol dehydrogenase
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of DHDH mRNA]
CTD
PMID:29891994
NCBI chr 1:95,954,361...95,965,262
Ensembl chr 1:95,953,092...95,965,197
G
Dmbt1
deleted in malignant brain tumors 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of DMBT1 mRNA; XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of DMBT1 mRNA]
CTD
PMID:27935865 PMID:29891994
NCBI chr 1:185,617,469...185,696,476
Ensembl chr 1:185,617,294...185,696,478
G
Dmrta1
DMRT-like family A1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of DMRTA1 mRNA
CTD
PMID:27935865
NCBI chr 5:104,415,893...104,422,433
Ensembl chr 5:104,415,893...104,422,433
G
Dpt
dermatopontin
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of DPT mRNA
CTD
PMID:27935865
NCBI chr13:77,123,224...77,151,646
Ensembl chr13:77,123,115...77,151,639
G
Drd1
dopamine receptor D1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of DRD1 mRNA
CTD
PMID:27935865
NCBI chr17:10,540,440...10,544,971
Ensembl chr17:10,540,558...10,545,002
G
Edn3
endothelin 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of EDN3 mRNA
CTD
PMID:27935865
NCBI chr 3:163,562,307...163,586,636
Ensembl chr 3:163,562,520...163,585,093
G
Eef1a2
eukaryotic translation elongation factor 1 alpha 2
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of EEF1A2 mRNA]
CTD
PMID:29891994
NCBI chr 3:168,265,893...168,275,071
Ensembl chr 3:168,195,357...168,275,071
G
Egf
epidermal growth factor
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of EGF mRNA
CTD
PMID:27935865
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
G
Epha3
Eph receptor A3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of EPHA3 mRNA
CTD
PMID:27935865
NCBI chr11:1,138,485...1,474,102
Ensembl chr11:1,140,985...1,473,900
G
Epha5
EPH receptor A5
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of EPHA5 mRNA
CTD
PMID:27935865
NCBI chr14:23,653,393...24,020,129
Ensembl chr14:23,653,393...24,017,317
G
Epyc
epiphycan
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of EPYC mRNA
CTD
PMID:27935865
NCBI chr 7:32,436,620...32,474,326
Ensembl chr 7:32,436,620...32,474,135
G
F2rl1
F2R like trypsin receptor 1
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of F2RL1 mRNA]
CTD
PMID:29891994
NCBI chr 2:26,772,274...26,785,226
Ensembl chr 2:26,772,278...26,785,226
G
F2rl3
F2R like thrombin or trypsin receptor 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of F2RL3 mRNA
CTD
PMID:27935865
NCBI chr16:17,117,441...17,119,434
Ensembl chr16:17,117,441...17,119,472
G
F3
coagulation factor III, tissue factor
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of F3 mRNA]
CTD
PMID:29891994
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
G
Fam13c
family with sequence similarity 13, member C
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of FAM13C mRNA
CTD
PMID:27935865
NCBI chr20:18,065,625...18,187,792
Ensembl chr20:18,065,628...18,187,592
G
Fam240b
family with sequence similarity 240 member B
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of FAM240B mRNA
CTD
PMID:27935865
NCBI chr17:647,269...663,209
Ensembl chr17:657,303...663,206
G
Fat2
FAT atypical cadherin 2
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of FAT2 mRNA]
CTD
PMID:29891994
NCBI chr10:39,364,072...39,456,324
Ensembl chr10:39,364,073...39,456,216
G
Fbln7
fibulin 7
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of FBLN7 mRNA
CTD
PMID:27935865
NCBI chr 3:116,111,581...116,145,839
Ensembl chr 3:116,111,677...116,147,983
G
Fbxo40
F-box protein 40
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of FBXO40 mRNA
CTD
PMID:27935865
NCBI chr11:63,794,452...63,812,697
Ensembl chr11:63,794,624...63,812,697
G
Fcrl2
Fc receptor-like 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of FCRL2 mRNA
CTD
PMID:27935865
NCBI chr 2:172,694,308...172,707,261
Ensembl chr 2:172,694,308...172,707,051
G
Fhod3
formin homology 2 domain containing 3
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of FHOD3 mRNA]
CTD
PMID:29891994
NCBI chr18:15,993,079...16,425,796
Ensembl chr18:15,993,324...16,425,796
G
Foxn4
forkhead box N4
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of FOXN4 mRNA
CTD
PMID:27935865
NCBI chr12:42,336,706...42,359,932
Ensembl chr12:42,340,323...42,359,921
G
Fpr2
formyl peptide receptor 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of FPR2 mRNA
CTD
PMID:27935865
NCBI chr 1:58,776,592...58,785,227
Ensembl chr 1:58,776,752...58,786,019
G
Frem1
Fras1 related extracellular matrix 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of FREM1 mRNA
CTD
PMID:27935865
NCBI chr 5:97,321,266...97,469,523
Ensembl chr 5:97,322,538...97,469,543
G
Frmpd4
FERM and PDZ domain containing 4
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of FRMPD4 mRNA
CTD
PMID:27935865
NCBI chr X:25,853,849...26,814,642
Ensembl chr X:25,853,934...26,814,637
G
Frzb
frizzled-related protein
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of FRZB mRNA
CTD
PMID:27935865
NCBI chr 3:65,332,274...65,365,208
Ensembl chr 3:65,332,277...65,365,208
G
Gabra4
gamma-aminobutyric acid type A receptor subunit alpha 4
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of GABRA4 mRNA
CTD
PMID:27935865
NCBI chr14:36,590,782...36,667,724
Ensembl chr14:36,590,782...36,665,844
G
Gal3st2
galactose-3-O-sulfotransferase 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of GAL3ST2 mRNA
CTD
PMID:27935865
NCBI chr 9:94,382,456...94,387,990
G
Gask1a
golgi associated kinase 1A
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of GASK1A mRNA
CTD
PMID:27935865
NCBI chr 8:121,610,779...121,643,742
Ensembl chr 8:121,610,787...121,642,942
G
Gcnt4
glucosaminyl (N-acetyl) transferase 4
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of GCNT4 mRNA
CTD
PMID:27935865
NCBI chr 2:28,253,325...28,283,082
Ensembl chr 2:28,252,860...28,283,082
G
Gdf10
growth differentiation factor 10
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of GDF10 mRNA
CTD
PMID:27935865
NCBI chr16:9,237,182...9,250,537
Ensembl chr16:9,237,261...9,249,343
G
Gfra3
GDNF family receptor alpha 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of GFRA3 mRNA
CTD
PMID:27935865
NCBI chr18:26,297,828...26,326,105
Ensembl chr18:26,297,829...26,326,105
G
Gja3
gap junction protein, alpha 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of GJA3 mRNA
CTD
PMID:27935865
NCBI chr15:31,181,360...31,206,820
Ensembl chr15:31,181,369...31,206,810
G
Gprasp2
G protein-coupled receptor associated sorting protein 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of GPRASP2 mRNA
CTD
PMID:27935865
NCBI chr X:98,817,668...98,823,814
Ensembl chr X:98,817,593...98,824,402
G
Gstk1
glutathione S-transferase kappa 1
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of GSTK1 mRNA]
CTD
PMID:29891994
NCBI chr 4:71,118,979...71,123,298
Ensembl chr 4:71,118,896...71,123,292
G
Gstz1
glutathione S-transferase zeta 1
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of GSTZ1 mRNA]
CTD
PMID:29891994
NCBI chr 6:106,794,594...106,805,284
Ensembl chr 6:106,794,074...106,805,284
G
Hes1
hes family bHLH transcription factor 1
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of HES1 mRNA]
CTD
PMID:29891994
NCBI chr11:70,705,763...70,708,176
Ensembl chr11:70,705,764...70,708,192
G
Hhip
Hedgehog-interacting protein
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of HHIP mRNA
CTD
PMID:27935865
NCBI chr19:27,863,684...27,952,528
Ensembl chr19:27,863,213...27,952,528
G
Hsd17b8
hydroxysteroid (17-beta) dehydrogenase 8
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of HSD17B8 mRNA]
CTD
PMID:29891994
NCBI chr20:4,826,725...4,828,742
Ensembl chr20:4,822,026...4,828,742
G
Htr2b
5-hydroxytryptamine receptor 2B
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of HTR2B mRNA
CTD
PMID:27935865
NCBI chr 9:86,735,793...86,756,638
Ensembl chr 9:86,742,102...86,755,108
G
Idh2
isocitrate dehydrogenase (NADP(+)) 2
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of IDH2 mRNA]
CTD
PMID:29891994
NCBI chr 1:134,038,644...134,057,969
Ensembl chr 1:134,029,772...134,058,025
G
Ido1
indoleamine 2,3-dioxygenase 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of IDO1 mRNA
CTD
PMID:27935865
NCBI chr16:67,430,654...67,442,726
Ensembl chr16:67,430,578...67,442,730
G
Ifi27l2a
interferon, alpha-inducible protein 27 like 2A
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of IFI27L2 mRNA]
CTD
PMID:29891994
NCBI chr 6:122,598,872...122,600,358
Ensembl chr 6:122,598,872...122,600,360
G
Il19
interleukin 19
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of IL19 mRNA
CTD
PMID:27935865
NCBI chr13:42,397,715...42,411,637
Ensembl chr13:42,399,138...42,405,473
G
Il1b
interleukin 1 beta
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of IL1B mRNA
CTD
PMID:27935865
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Inmt
indolethylamine N-methyltransferase
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of INMT mRNA
CTD
PMID:27935865
NCBI chr 4:84,318,197...84,322,493
Ensembl chr 4:84,318,197...84,322,493
G
Irf7
interferon regulatory factor 7
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of IRF7 mRNA]
CTD
PMID:29891994
NCBI chr 1:196,367,380...196,370,943
Ensembl chr 1:196,367,361...196,370,832
G
Irs2
insulin receptor substrate 2
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of IRS2 mRNA]
CTD
PMID:29891994
NCBI chr16:78,488,249...78,512,482
Ensembl chr16:78,485,045...78,512,482
G
Isg15
ISG15 ubiquitin-like modifier
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of ISG15 mRNA]
CTD
PMID:29891994
NCBI chr 5:166,784,148...166,785,435
Ensembl chr 5:166,784,148...166,785,435
G
Itpr1
inositol 1,4,5-trisphosphate receptor, type 1
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of ITPR1 mRNA]
CTD
PMID:29891994
NCBI chr 4:141,187,377...141,554,240
Ensembl chr 4:141,187,418...141,510,491
G
Itpr3
inositol 1,4,5-trisphosphate receptor, type 3
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of ITPR3 mRNA]
CTD
PMID:29891994
NCBI chr20:5,136,968...5,202,339
Ensembl chr20:5,136,441...5,202,337
G
Jchain
joining chain of multimeric IgA and IgM
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of JCHAIN mRNA
CTD
PMID:27935865
NCBI chr14:19,538,927...19,547,023
Ensembl chr14:19,538,952...19,546,298
G
Kank4
KN motif and ankyrin repeat domains 4
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of KANK4 mRNA
CTD
PMID:27935865
NCBI chr 5:113,401,491...113,465,526
Ensembl chr 5:113,402,468...113,465,555
G
Kbtbd12
kelch repeat and BTB domain containing 12
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of KBTBD12 mRNA
CTD
PMID:27935865
NCBI chr 4:121,014,636...121,088,701
Ensembl chr 4:121,016,257...121,088,443
G
Kcna1
potassium voltage-gated channel subfamily A member 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of KCNA1 mRNA
CTD
PMID:27935865
NCBI chr 4:159,464,223...159,472,905
Ensembl chr 4:159,464,188...159,472,682
G
Kcnma1
potassium calcium-activated channel subfamily M alpha 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of KCNMA1 mRNA
CTD
PMID:27935865
NCBI chr15:302,480...1,007,675
Ensembl chr15:302,214...1,001,198
G
Klhl13
kelch-like family member 13
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of KLHL13 mRNA
CTD
PMID:27935865
NCBI chr X:113,942,309...114,107,299
Ensembl chr X:113,942,309...114,107,321
G
Klhl33
kelch-like family member 33
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of KLHL33 mRNA
CTD
PMID:27935865
NCBI chr15:24,105,923...24,114,445
Ensembl chr15:24,105,930...24,114,438
G
Klhl4
kelch-like family member 4
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of KLHL4 mRNA
CTD
PMID:27935865
NCBI chr X:79,429,193...79,719,482
Ensembl chr X:79,622,113...79,719,480
G
Klk6
kallikrein related-peptidase 6
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of KLK6 mRNA
CTD
PMID:27935865
NCBI chr 1:94,278,863...94,286,136
Ensembl chr 1:94,280,340...94,286,121
G
Kng2
kininogen 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of KNG2 mRNA
CTD
PMID:27935865
NCBI chr11:77,913,876...77,936,247
Ensembl chr11:77,909,612...78,002,971
G
Krt16
keratin 16
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of KRT16 mRNA
CTD
PMID:27935865
NCBI chr10:85,168,357...85,171,816
Ensembl chr10:85,066,802...85,171,799
G
Krt84
keratin 84
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of KRT84 mRNA
CTD
PMID:27935865
NCBI chr 7:132,649,064...132,656,885
Ensembl chr 7:132,649,061...132,656,874
G
Letmd1
LETM1 domain containing 1
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of LETMD1 mRNA]
CTD
PMID:29891994
NCBI chr 7:131,584,241...131,597,797
Ensembl chr 7:131,584,259...131,597,796
G
Lin28a
lin-28 homolog A
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of LIN28A mRNA
CTD
PMID:27935865
NCBI chr 5:146,227,119...146,244,122
Ensembl chr 5:146,227,119...146,244,122
G
Lipf
lipase F, gastric type
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of LIPF mRNA
CTD
PMID:27935865
NCBI chr 1:231,493,498...231,511,845
Ensembl chr 1:231,493,498...231,511,845
G
Lipn
lipase, family member N
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of LIPN mRNA
CTD
PMID:27935865
NCBI chr 1:231,584,950...231,603,456
Ensembl chr 1:231,584,956...231,603,468
G
Lman1l
lectin, mannose-binding, 1 like
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of LMAN1L mRNA
CTD
PMID:27935865
NCBI chr 8:58,010,839...58,029,599
Ensembl chr 8:58,010,839...58,023,681
G
Lmntd1
lamin tail domain containing 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of LMNTD1 mRNA
CTD
PMID:27935865
NCBI chr 4:178,354,302...178,588,483
Ensembl chr 4:178,354,137...178,588,477
G
Lmo4
LIM domain only 4
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of LMO4 mRNA]
CTD
PMID:29891994
NCBI chr 2:233,264,180...233,280,881
Ensembl chr 2:233,264,182...233,280,880
G
Lmod3
leiomodin 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of LMOD3 mRNA
CTD
PMID:27935865
NCBI chr 4:129,843,964...129,858,684
Ensembl chr 4:129,843,970...129,858,244
G
Lrg1
leucine-rich alpha-2-glycoprotein 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of LRG1 mRNA
CTD
PMID:27935865
NCBI chr 9:947,516...949,773
Ensembl chr 9:947,516...949,813
G
Lrrc3b
leucine rich repeat containing 3B
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of LRRC3B mRNA
CTD
PMID:27935865
NCBI chr15:9,973,580...10,050,891
Ensembl chr15:9,969,983...10,051,066
G
Lrrc4b
leucine rich repeat containing 4B
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of LRRC4B mRNA
CTD
PMID:27935865
NCBI chr 1:94,922,034...94,956,309
Ensembl chr 1:94,935,603...94,956,263
G
Mamstr
MEF2 activating motif and SAP domain containing transcriptional regulator
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MAMSTR mRNA
CTD
PMID:27935865
NCBI chr 1:96,109,715...96,116,295
Ensembl chr 1:96,110,343...96,115,744
G
Map1lc3a
microtubule-associated protein 1 light chain 3 alpha
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of MAP1LC3A mRNA]
CTD
PMID:29891994
NCBI chr 3:143,783,024...143,784,670
Ensembl chr 3:143,783,024...143,784,670
G
Mcidas
multiciliate differentiation and DNA synthesis associated cell cycle protein
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MCIDAS mRNA
CTD
PMID:27935865
NCBI chr 2:44,636,820...44,644,551
Ensembl chr 2:44,636,856...44,642,601
G
Mfap4
microfibril associated protein 4
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MFAP4 mRNA
CTD
PMID:27935865
NCBI chr10:46,167,158...46,170,176
Ensembl chr10:46,167,217...46,170,155
G
Mgam
maltase-glucoamylase
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of MGAM mRNA
CTD
PMID:27935865
NCBI chr 4:69,441,626...69,602,068
Ensembl chr 4:69,446,150...69,692,715
G
Mme
membrane metallo-endopeptidase
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MME mRNA
CTD
PMID:27935865
NCBI chr 2:147,686,913...147,803,808
Ensembl chr 2:147,722,086...147,803,792
G
Mmp10
matrix metallopeptidase 10
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of MMP10 mRNA
CTD
PMID:27935865
NCBI chr 8:4,689,840...4,697,748
Ensembl chr 8:4,689,840...4,697,748
G
Mmp8
matrix metallopeptidase 8
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of MMP8 mRNA
CTD
PMID:27935865
NCBI chr 8:4,724,009...4,733,864
Ensembl chr 8:4,724,029...4,733,520
G
Mstn
myostatin
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MSTN mRNA
CTD
PMID:27935865
NCBI chr 9:48,452,533...48,458,933
Ensembl chr 9:48,452,533...48,458,933
G
Msx3
msh homeobox 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of MSX3 mRNA
CTD
PMID:27935865
NCBI chr 1:194,839,041...194,842,209
Ensembl chr 1:194,839,041...194,841,969
G
Musk
muscle associated receptor tyrosine kinase
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MUSK mRNA
CTD
PMID:27935865
NCBI chr 5:73,058,427...73,169,696
Ensembl chr 5:73,058,121...73,171,932
G
Myadml2
myeloid-associated differentiation marker-like 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MYADML2 mRNA
CTD
PMID:27935865
NCBI chr10:105,922,557...105,927,867
Ensembl chr10:105,925,947...105,927,575
G
Myh13
myosin heavy chain 13
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MYH13 mRNA
CTD
PMID:27935865
NCBI chr10:52,012,779...52,068,960
Ensembl chr10:52,009,425...52,068,951
G
Myoc
myocilin
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MYOC mRNA
CTD
PMID:27935865
NCBI chr13:74,976,730...74,987,128
Ensembl chr13:74,976,730...74,987,127
G
Myocd
myocardin
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MYOCD mRNA
CTD
PMID:27935865
NCBI chr10:49,833,219...49,928,806
Ensembl chr10:49,836,641...49,927,627
G
Myog
myogenin
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MYOG mRNA
CTD
PMID:27935865
NCBI chr13:45,745,455...45,748,044
Ensembl chr13:45,745,436...45,748,039
G
Myoz3
myozenin 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MYOZ3 mRNA
CTD
PMID:27935865
NCBI chr18:54,026,133...54,046,151
Ensembl chr18:54,026,152...54,102,126
G
Nags
N-acetylglutamate synthase
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of NAGS mRNA
CTD
PMID:27935865
NCBI chr10:87,098,330...87,102,465
Ensembl chr10:87,098,330...87,102,465
G
Nell2
neural EGFL like 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of NELL2 mRNA
CTD
PMID:27935865
NCBI chr 7:126,343,089...126,662,903
Ensembl chr 7:126,198,851...126,733,503
G
Nfe2
nuclear factor, erythroid 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of NFE2 mRNA
CTD
PMID:27935865
NCBI chr 7:134,382,758...134,395,364
Ensembl chr 7:134,382,761...134,390,108
G
Nkx2-8
NK2 homeobox 8
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of NKX2-9 mRNA
CTD
PMID:27935865
NCBI chr 6:74,086,274...74,087,977
Ensembl chr 6:74,086,274...74,087,977
G
Nkx3-1
NK3 homeobox 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of NKX3-1 mRNA
CTD
PMID:27935865
NCBI chr15:44,473,851...44,476,443
Ensembl chr15:44,473,851...44,476,441
G
Nlrp12
NLR family, pyrin domain containing 12
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of NLRP12 mRNA
CTD
PMID:27935865
NCBI chr 1:65,932,610...65,969,873
Ensembl chr 1:65,932,595...65,960,934
G
Nlrp3
NLR family, pyrin domain containing 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of NLRP3 mRNA
CTD
PMID:27935865
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
G
Npy
neuropeptide Y
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of NPY mRNA
CTD
PMID:27935865
NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:78,881,264...78,888,495
G
Ntf3
neurotrophin 3
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of NTF3 mRNA]
CTD
PMID:29891994
NCBI chr 4:158,914,984...158,984,453
Ensembl chr 4:158,914,957...158,984,596
G
Olfml1
olfactomedin-like 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of OLFML1 mRNA
CTD
PMID:27935865
NCBI chr 1:161,478,129...161,502,541
Ensembl chr 1:161,478,242...161,502,537
G
Opcml
opioid binding protein/cell adhesion molecule-like
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of OPCML mRNA
CTD
PMID:27935865
NCBI chr 8:26,788,988...27,304,551
Ensembl chr 8:26,192,841...27,300,620
G
Otop2
otopetrin 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of OTOP2 mRNA
CTD
PMID:27935865
NCBI chr10:100,564,727...100,574,298
Ensembl chr10:100,564,727...100,574,298
G
P2rx4
purinergic receptor P2X 4
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of P2RX4 mRNA]
CTD
PMID:29891994
NCBI chr12:33,844,609...33,862,265
Ensembl chr12:33,844,396...33,862,253
G
Pax1
paired box 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PAX1 mRNA
CTD
PMID:27935865
NCBI chr 3:134,792,330...134,801,637
Ensembl chr 3:134,789,182...134,801,636
G
Pax7
paired box 7
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PAX7 mRNA
CTD
PMID:27935865
NCBI chr 5:151,996,368...152,098,023
Ensembl chr 5:151,999,092...152,097,979
G
Pck1
phosphoenolpyruvate carboxykinase 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PCK1 mRNA
CTD
PMID:27935865
NCBI chr 3:161,930,256...161,936,205
Ensembl chr 3:161,930,256...161,936,191
G
Pck2
phosphoenolpyruvate carboxykinase 2 (mitochondrial)
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of PCK2 mRNA]
CTD
PMID:29891994
NCBI chr15:29,027,891...29,036,729
Ensembl chr15:29,027,894...29,037,283
G
Pde3a
phosphodiesterase 3A
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PDE3A mRNA
CTD
PMID:27935865
NCBI chr 4:174,172,804...174,443,944
Ensembl chr 4:174,172,868...174,438,274
G
Perm1
PPARGC1 and ESRR induced regulator, muscle 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PERM1 mRNA
CTD
PMID:27935865
NCBI chr 5:166,800,030...166,805,323
Ensembl chr 5:166,800,030...166,805,323
G
Pgm5
phosphoglucomutase 5
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PGM5 mRNA
CTD
PMID:27935865
NCBI chr 1:222,325,638...222,513,434
Ensembl chr 1:222,325,643...222,513,437
G
Pgr
progesterone receptor
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PGR mRNA
CTD
PMID:27935865
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
G
Phex
phosphate regulating endopeptidase X-linked
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PHEX mRNA
CTD
PMID:27935865
NCBI chr X:37,607,553...37,856,183
Ensembl chr X:37,610,760...37,854,469
G
Pira2
paired-Ig-like receptor A2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of LILRA6 mRNA
CTD
PMID:27935865
NCBI chr 1:65,352,125...65,422,842
Ensembl chr 1:65,415,946...65,422,853
G
Pitx2
paired-like homeodomain 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PITX2 mRNA
CTD
PMID:27935865
NCBI chr 2:217,717,738...217,737,293
Ensembl chr 2:217,717,693...217,737,293
G
Pkhd1l1
PKHD1 like 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PKHD1L1 mRNA
CTD
PMID:27935865
NCBI chr 7:75,620,384...75,795,335
Ensembl chr 7:75,620,484...75,795,335
G
Pkn1
protein kinase N1
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of PKN1 mRNA]
CTD
PMID:29891994
NCBI chr19:24,442,130...24,470,107
Ensembl chr19:24,442,122...24,470,107
G
Plcb4
phospholipase C, beta 4
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of PLCB4 mRNA]
CTD
PMID:29891994
NCBI chr 3:122,952,965...123,322,522
Ensembl chr 3:122,953,196...123,322,392
G
Plin1
perilipin 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PLIN1 mRNA
CTD
PMID:27935865
NCBI chr 1:133,664,294...133,676,854
Ensembl chr 1:133,664,892...133,676,828
G
Polr1h
RNA polymerase I subunit H
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of POLR1H mRNA]
CTD
PMID:29891994
NCBI chr20:1,594,936...1,598,854
Ensembl chr20:1,594,936...1,598,854
G
Ppbp
pro-platelet basic protein
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of PPBP mRNA
CTD
PMID:27935865
NCBI chr14:17,302,326...17,303,130
Ensembl chr14:17,302,326...17,303,130
G
Prap1
proline-rich acidic protein 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of PRAP1 mRNA
CTD
PMID:27935865
NCBI chr 1:194,883,078...194,886,874
Ensembl chr 1:194,883,078...194,886,872
G
Prdm6
PR/SET domain 6
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PRDM6 mRNA
CTD
PMID:27935865
NCBI chr18:46,904,115...47,008,482
Ensembl chr18:46,904,127...47,007,823
G
Prok2
prokineticin 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of PROK2 mRNA
CTD
PMID:27935865
NCBI chr 4:132,346,681...132,361,754
Ensembl chr 4:132,347,103...132,361,385
G
Prr32
proline rich 32
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PRR32 mRNA
CTD
PMID:27935865
NCBI chr X:123,978,010...123,979,928
Ensembl chr X:123,977,985...123,979,942
G
Psors1c2
psoriasis susceptibility 1 candidate 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of PSORS1C2 mRNA
CTD
PMID:27935865
NCBI chr20:3,202,178...3,203,599
Ensembl chr20:3,202,174...3,203,599
G
Ptgdr
prostaglandin D2 receptor
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PTGDR mRNA
CTD
PMID:27935865
NCBI chr15:17,360,304...17,367,679
Ensembl chr15:17,360,304...17,367,679
G
Ptgfr
prostaglandin F receptor
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PTGFR mRNA
CTD
PMID:27935865
NCBI chr 2:240,731,185...240,766,674
Ensembl chr 2:240,733,375...240,765,650
G
Pwwp2b
PWWP domain containing 2B
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of PWWP2B mRNA]
CTD
PMID:29891994
NCBI chr 1:194,040,395...194,059,979
Ensembl chr 1:194,041,341...194,059,958
G
Pxmp2
peroxisomal membrane protein 2
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of PXMP2 mRNA]
CTD
PMID:29891994
NCBI chr12:46,394,051...46,404,561
Ensembl chr12:46,394,193...46,404,557
G
Pycr1
pyrroline-5-carboxylate reductase 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PYCR1 mRNA; XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of PYCR1 mRNA]
CTD
PMID:27935865 PMID:29891994
NCBI chr10:105,917,732...105,922,658
Ensembl chr10:105,917,680...105,922,549
G
Rab17
RAB17, member RAS oncogene family
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of RAB17 mRNA]
CTD
PMID:29891994
NCBI chr 9:91,552,924...91,566,759
Ensembl chr 9:91,553,464...91,566,451
G
Rab2b
RAB2B, member RAS oncogene family
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of RAB2B mRNA]
CTD
PMID:29891994
NCBI chr15:24,968,364...24,988,990
Ensembl chr15:24,968,803...24,989,113
G
Rap1gap
Rap1 GTPase-activating protein
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of RAP1GAP mRNA]
CTD
PMID:29891994
NCBI chr 5:149,873,987...149,939,254
Ensembl chr 5:149,892,019...149,939,253
G
Rasd2
RASD family, member 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of RASD2 mRNA
CTD
PMID:27935865
NCBI chr19:13,594,291...13,605,016
Ensembl chr19:13,594,291...13,605,016
G
Rcan2
regulator of calcineurin 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of RCAN2 mRNA
CTD
PMID:27935865
NCBI chr 9:16,959,478...17,174,823
Ensembl chr 9:16,959,480...17,174,856
G
Rdm1
RAD52 motif containing 1
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of RDM1 mRNA]
CTD
PMID:29891994
NCBI chr10:86,562,871...86,573,034
Ensembl chr10:86,539,553...86,573,034
G
Retn
resistin
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of RETN mRNA
CTD
PMID:27935865
NCBI chr12:1,710,881...1,712,621
Ensembl chr12:1,710,881...1,712,620
G
Ripply1
ripply transcriptional repressor 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of RIPPLY1 mRNA
CTD
PMID:27935865
NCBI chr X:103,436,731...103,440,904
Ensembl chr X:103,436,729...103,443,349
G
Robo4
roundabout guidance receptor 4
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ROBO4 mRNA
CTD
PMID:27935865
NCBI chr 8:37,119,953...37,133,887
Ensembl chr 8:37,119,988...37,132,519
G
Rras
RAS related
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of RRAS mRNA]
CTD
PMID:29891994
NCBI chr 1:95,500,582...95,504,362
Ensembl chr 1:95,500,566...95,504,357
G
Rtl3
retrotransposon Gag like 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of RTL3 mRNA
CTD
PMID:27935865
NCBI chr X:71,947,343...71,951,008
Ensembl chr X:71,948,253...71,950,121
G
Rtl8a
retrotransposon Gag like 8A
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of RTL8A mRNA]
CTD
PMID:29891994
NCBI chr X:133,414,027...133,415,240
Ensembl chr X:133,414,030...133,415,240
G
Runx1t1
RUNX1 partner transcriptional co-repressor 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of RUNX1T1 mRNA
CTD
PMID:27935865
NCBI chr 5:27,187,674...27,338,070
Ensembl chr 5:27,187,551...27,335,592
G
S100a8
S100 calcium binding protein A8
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of S100A8 mRNA
CTD
PMID:27935865
NCBI chr 2:176,166,517...176,167,645
Ensembl chr 2:176,167,124...176,167,643
G
S100a9
S100 calcium binding protein A9
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of S100A9 mRNA
CTD
PMID:27935865
NCBI chr 2:176,190,361...176,193,182
Ensembl chr 2:176,190,361...176,193,230
G
Samsn1
SAM domain, SH3 domain and nuclear localization signals, 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SAMSN1 mRNA
CTD
PMID:27935865
NCBI chr11:14,484,523...14,534,900
Ensembl chr11:14,483,893...14,534,900
G
Sbk2
SH3 domain binding kinase family, member 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SBK2 mRNA
CTD
PMID:27935865
NCBI chr 1:68,874,081...68,881,918
Ensembl chr 1:68,874,152...68,881,916
G
Scg3
secretogranin III
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SCG3 mRNA
CTD
PMID:27935865
NCBI chr 8:76,399,777...76,442,015
Ensembl chr 8:76,399,777...76,442,015
G
Sell
selectin L
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SELL mRNA
CTD
PMID:27935865
NCBI chr13:76,416,969...76,436,444
Ensembl chr13:76,416,915...76,436,456
G
Selp
selectin P
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SELP mRNA
CTD
PMID:27935865
NCBI chr13:76,476,229...76,511,846
Ensembl chr13:76,476,295...76,511,845
G
Sfrp1
secreted frizzled-related protein 1
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of SFRP1 mRNA]
CTD
PMID:29891994
NCBI chr16:68,575,763...68,614,180
Ensembl chr16:68,575,763...68,614,286
G
Sh2d5
SH2 domain containing 5
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SH2D5 mRNA
CTD
PMID:27935865
NCBI chr 5:150,469,738...150,480,615
Ensembl chr 5:150,467,728...150,479,955
G
Shisa8
shisa family member 8
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SHISA8 mRNA
CTD
PMID:27935865
NCBI chr 7:113,722,408...113,727,858
Ensembl chr 7:113,722,408...113,727,858
G
Shox2
SHOX homeobox 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SHOX2 mRNA
CTD
PMID:27935865
NCBI chr 2:151,217,049...151,227,180
Ensembl chr 2:151,217,552...151,227,143
G
Slc12a8
solute carrier family 12, member 8
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SLC12A8 mRNA
CTD
PMID:27935865
NCBI chr11:67,116,876...67,266,548
Ensembl chr11:67,116,877...67,266,834
G
Slc1a3
solute carrier family 1 member 3
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of SLC1A3 mRNA]
CTD
PMID:29891994
NCBI chr 2:57,755,495...57,830,605
Ensembl chr 2:57,755,497...57,830,605
G
Slc1a5
solute carrier family 1 member 5
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of SLC1A5 mRNA]
CTD
PMID:29891994
NCBI chr 1:77,456,849...77,470,952
Ensembl chr 1:77,456,694...77,470,952
G
Slc25a34
solute carrier family 25, member 34
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SLC25A34 mRNA
CTD
PMID:27935865
NCBI chr 5:153,932,081...153,936,854
G
Slc26a7
solute carrier family 26 member 7
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SLC26A7 mRNA
CTD
PMID:27935865
NCBI chr 5:27,884,400...28,021,865
Ensembl chr 5:27,887,042...28,021,658
G
Slc2a13
solute carrier family 2 member 13
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SLC2A13 mRNA
CTD
PMID:27935865
NCBI chr 7:122,399,329...122,726,605
Ensembl chr 7:122,399,330...122,726,605
G
Slc2a3
solute carrier family 2 member 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SLC2A3 mRNA
CTD
PMID:27935865
NCBI chr 4:155,960,944...156,026,000
Ensembl chr 4:155,960,946...156,025,472
G
Slc38a11
solute carrier family 38, member 11
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SLC38A11 mRNA
CTD
PMID:27935865
NCBI chr 3:49,987,119...50,033,615
Ensembl chr 3:49,987,124...50,033,615
G
Slc38a5
solute carrier family 38, member 5
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SLC38A5 mRNA
CTD
PMID:27935865
NCBI chr X:14,213,727...14,222,498
Ensembl chr X:14,213,729...14,222,498
G
Slc5a7
solute carrier family 5 member 7
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SLC5A7 mRNA
CTD
PMID:27935865
NCBI chr 9:7,595,440...7,626,258
Ensembl chr 9:7,595,444...7,626,258
G
Slc6a12
solute carrier family 6 member 12
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SLC6A12 mRNA
CTD
PMID:27935865
NCBI chr 4:154,585,386...154,603,750
Ensembl chr 4:154,585,500...154,603,750
G
Sln
sarcolipin
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SLN mRNA
CTD
PMID:27935865
NCBI chr 8:54,221,389...54,248,110
Ensembl chr 8:54,243,542...54,247,791
G
Snph
syntaphilin
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SNPH mRNA
CTD
PMID:27935865
NCBI chr 3:140,098,540...140,139,342
Ensembl chr 3:140,099,708...140,139,453
G
Sorcs1
sortilin-related VPS10 domain containing receptor 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SORCS1 mRNA
CTD
PMID:27935865
NCBI chr 1:249,080,662...249,594,520
Ensembl chr 1:249,081,355...249,594,507
G
Sox10
SRY-box transcription factor 10
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SOX10 mRNA
CTD
PMID:27935865
NCBI chr 7:110,725,274...110,734,651
Ensembl chr 7:110,725,274...110,735,544
G
Sox9
SRY-box transcription factor 9
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of SOX9 mRNA]
CTD
PMID:29891994
NCBI chr10:97,806,485...97,811,994
Ensembl chr10:97,806,485...97,811,994
G
Spats2l
spermatogenesis associated, serine-rich 2-like
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of SPATS2L mRNA]
CTD
PMID:29891994
NCBI chr 9:59,319,949...59,493,864
Ensembl chr 9:59,320,276...59,493,967
G
Spon1
spondin 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SPON1 mRNA
CTD
PMID:27935865
NCBI chr 1:167,929,049...168,228,239
Ensembl chr 1:167,928,972...168,228,226
G
Sprr1b
small proline-rich protein 1B
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SPRR1B mRNA
CTD
PMID:27935865
NCBI chr 2:178,008,844...178,010,742
Ensembl chr 2:178,009,130...178,009,567
G
Sprr2a
small proline rich protein 2A
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SPRR2H mRNA
CTD
PMID:27935865
NCBI chr 2:177,815,964...177,816,236
Ensembl chr 2:177,815,964...177,816,236
G
Sprr2b
small proline rich protein 2B
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SPRR2B mRNA
CTD
PMID:27935865
NCBI chr 2:177,852,824...177,853,096
Ensembl chr 2:177,852,824...177,853,096
G
Sprr2d
small proline-rich protein 2D
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SPRR2D mRNA
CTD
PMID:27935865
NCBI chr 2:177,870,082...177,870,679
Ensembl chr 2:177,870,434...177,870,679
G
Sprr2f
small proline rich protein 2F
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SPRR2F mRNA
CTD
PMID:27935865
NCBI chr 2:177,989,974...177,990,204
Ensembl chr 2:177,989,974...177,990,204
G
Srgn
serglycin
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SRGN mRNA
CTD
PMID:27935865
NCBI chr20:30,442,810...30,479,549
Ensembl chr20:30,442,813...30,457,406
G
Srpx
sushi-repeat-containing protein, X-linked
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SRPX mRNA
CTD
PMID:27935865
NCBI chr X:12,676,984...12,751,296
Ensembl chr X:12,566,645...12,747,882
G
St6galnac2
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of ST6GALNAC2 mRNA]
CTD
PMID:29891994
NCBI chr10:101,910,220...101,928,412
Ensembl chr10:101,909,971...101,915,008 Ensembl chr10:101,909,971...101,915,008
G
Stard10
StAR-related lipid transfer domain containing 10
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of STARD10 mRNA]
CTD
PMID:29891994
NCBI chr 1:155,722,637...155,748,007
Ensembl chr 1:155,718,389...155,747,094
G
Stc2
stanniocalcin 2
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of STC2 mRNA]
CTD
PMID:29891994
NCBI chr10:16,251,046...16,260,815
Ensembl chr10:16,250,853...16,262,973
G
Stxbp5l
syntaxin binding protein 5L
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of STXBP5L mRNA
CTD
PMID:27935865
NCBI chr11:63,334,667...63,654,270
Ensembl chr11:63,334,667...63,657,014
G
Susd5
sushi domain containing 5
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SUSD5 mRNA
CTD
PMID:27935865
NCBI chr 8:113,996,771...114,036,133
Ensembl chr 8:113,997,362...114,035,861
G
Svopl
SVOP like
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SVOPL mRNA
CTD
PMID:27935865
NCBI chr 4:66,697,550...66,751,699
Ensembl chr 4:66,698,177...66,758,978
G
Tagln
transgelin
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TAGLN mRNA; XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of TAGLN mRNA]
CTD
PMID:27935865 PMID:29891994
NCBI chr 8:46,224,939...46,230,413
Ensembl chr 8:46,222,472...46,230,668
G
Tarm1
T cell-interacting, activating receptor on myeloid cells 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of TARM1 mRNA
CTD
PMID:27935865
NCBI chr 1:65,666,742...65,682,402
Ensembl chr 1:65,671,902...65,679,626
G
Tbc1d16
TBC1 domain family, member 16
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of TBC1D16 mRNA]
CTD
PMID:29891994
NCBI chr10:104,400,963...104,486,698
Ensembl chr10:104,402,398...104,486,670
G
Tbx15
T-box transcription factor 15
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TBX15 mRNA
CTD
PMID:27935865
NCBI chr 2:186,576,650...186,687,748
Ensembl chr 2:186,576,676...186,687,663
G
Tbxa2r
thromboxane A2 receptor
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TBXA2R mRNA
CTD
PMID:27935865
NCBI chr 7:8,383,347...8,390,753
Ensembl chr 7:8,383,378...8,388,176
G
Tdo2
tryptophan 2,3-dioxygenase
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TDO2 mRNA
CTD
PMID:27935865
NCBI chr 2:167,269,581...167,287,511
Ensembl chr 2:167,269,579...167,287,511
G
Tff2
trefoil factor 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TFF2 mRNA
CTD
PMID:27935865
NCBI chr20:9,215,750...9,219,619
Ensembl chr20:9,215,761...9,219,619
G
Tgm2
transglutaminase 2
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of TGM2 mRNA]
CTD
PMID:29891994
NCBI chr 3:146,772,684...146,801,924
Ensembl chr 3:146,772,687...146,801,981
G
Thrsp
thyroid hormone responsive
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of THRSP mRNA
CTD
PMID:27935865
NCBI chr 1:151,723,415...151,727,740
Ensembl chr 1:151,723,086...151,728,075
G
Timp1
TIMP metallopeptidase inhibitor 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of TIMP1 mRNA
CTD
PMID:27935865
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
G
Tmem132c
transmembrane protein 132C
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TMEM132C mRNA
CTD
PMID:27935865
NCBI chr12:29,115,213...29,437,900
Ensembl chr12:29,116,467...29,437,870
G
Tmem182
transmembrane protein 182
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TMEM182 mRNA
CTD
PMID:27935865
NCBI chr 9:43,059,432...43,111,318
Ensembl chr 9:43,059,439...43,111,317
G
Tmem252
transmembrane protein 252
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of TMEM252 mRNA
CTD
PMID:27935865
NCBI chr 1:222,316,982...222,321,946
Ensembl chr 1:222,316,795...222,321,943
G
Tmem255a
transmembrane protein 255A
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TMEM255A mRNA
CTD
PMID:27935865
NCBI chr X:116,970,793...117,035,008
Ensembl chr X:116,970,695...117,035,008
G
Tmem30b
transmembrane protein 30B
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of TMEM30B mRNA]
CTD
PMID:29891994
NCBI chr 6:92,251,626...92,254,702
Ensembl chr 6:92,249,790...92,254,842
G
Tnc
tenascin C
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of TNC mRNA]
CTD
PMID:29891994
NCBI chr 5:77,375,851...77,460,712
Ensembl chr 5:77,375,851...77,460,624
G
Tnfrsf14
TNF receptor superfamily member 14
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of TNFRSF14 mRNA]
CTD
PMID:29891994
NCBI chr 5:165,486,069...165,494,421
Ensembl chr 5:165,484,262...165,493,703
G
Tnfsf14
TNF superfamily member 14
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of TNFSF14 mRNA
CTD
PMID:27935865
NCBI chr 9:2,068,295...2,073,128
Ensembl chr 9:2,069,104...2,073,216
G
Tnfsf9
TNF superfamily member 9
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of TNFSF9 mRNA
CTD
PMID:27935865
NCBI chr 9:1,944,017...1,946,351
Ensembl chr 9:1,944,017...1,946,345
G
Tnni2
troponin I2, fast skeletal type
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of TNNI2 mRNA]
CTD
PMID:29891994
NCBI chr 1:197,595,012...197,597,554
Ensembl chr 1:197,594,813...197,597,560
G
Tnnt1
troponin T1, slow skeletal type
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TNNT1 mRNA
CTD
PMID:27935865
NCBI chr 1:69,306,362...69,316,721
Ensembl chr 1:69,306,362...69,316,721
G
Tpd52l1
TPD52 like 1
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of TPD52L1 mRNA]
CTD
PMID:29891994
NCBI chr 1:26,172,038...26,290,704
Ensembl chr 1:26,172,170...26,291,109
G
Trarg1
trafficking regulator of GLUT4 (SLC2A4) 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TRARG1 mRNA
CTD
PMID:27935865
NCBI chr10:61,521,107...61,541,494
Ensembl chr10:61,521,107...61,541,494
G
Trem1
triggering receptor expressed on myeloid cells 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of TREM1 mRNA
CTD
PMID:27935865
NCBI chr 9:12,763,819...12,779,285
Ensembl chr 9:12,763,819...12,779,203
G
Tril
TLR4 interactor with leucine-rich repeats
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TRIL mRNA
CTD
PMID:27935865
NCBI chr 4:82,922,327...82,927,172
Ensembl chr 4:82,922,328...82,927,172
G
Tst
thiosulfate sulfurtransferase
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of TST mRNA]
CTD
PMID:29891994
NCBI chr 7:109,948,061...109,955,378
Ensembl chr 7:109,948,062...109,957,216
G
Tubb3
tubulin, beta 3 class III
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of TUBB3 mRNA
CTD
PMID:27935865
NCBI chr19:51,457,187...51,466,243
Ensembl chr19:51,457,184...51,466,243
G
Twist2
twist family bHLH transcription factor 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TWIST2 mRNA
CTD
PMID:27935865
NCBI chr 9:92,374,740...92,419,222
Ensembl chr 9:92,374,574...92,419,222
G
Txlnb
taxilin beta
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TXLNB mRNA
CTD
PMID:27935865
NCBI chr 1:12,404,845...12,449,977
Ensembl chr 1:12,404,859...12,449,975
G
Upk3a
uroplakin 3A
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of UPK3A mRNA
CTD
PMID:27935865
NCBI chr 7:116,128,981...116,139,950
Ensembl chr 7:116,134,874...116,139,948
G
Wfdc17
WAP four-disulfide core domain 17
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of WFDC17 mRNA
CTD
PMID:27935865
NCBI chr10:68,561,954...68,562,801
Ensembl chr10:68,561,954...68,562,801
G
Wnt2b
Wnt family member 2B
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of WNT2B mRNA
CTD
PMID:27935865
NCBI chr 2:192,454,226...192,468,599
Ensembl chr 2:192,453,824...192,470,308
G
Zfp366
zinc finger protein 366
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ZFP366 mRNA
CTD
PMID:27935865
NCBI chr 2:30,578,552...30,640,546
Ensembl chr 2:30,578,715...30,642,182
G
Zfp524
zinc finger protein 524
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of ZNF524 mRNA]
CTD
PMID:29891994
NCBI chr 1:68,824,803...68,828,363
Ensembl chr 1:68,824,803...68,828,594
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all
Path 1
CHEBI ontology
19874
chemical entity
19872
atom
19872
nonmetal atom
19794
nitrogen atom
18974
nitrogen molecular entity
18974
organonitrogen compound
18827
organonitrogen heterocyclic compound
18148
benzothiadiazole
311
(2S)-2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-2-phenyl-N-pyridin-4-ylacetamide
0
(2S)-2-[3-(aminomethyl)phenyl]-3-[(S)-\{(1R)-1-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-2-methylpropyl\}(hydroxy)phosphoryl]propanoic acid
0
1,2,3-benzothiadiazole-7-carboxylic acid
0
1-(1,3-benzodioxol-5-ylmethyl)-3-(2,1,3-benzothiadiazol-5-yl)thiourea
0
1-(2,1,3-benzothiadiazol-4-ylsulfonyl)-N-(6-methyl-1,3-benzothiazol-2-yl)-3-piperidinecarboxamide
0
4-methyl-N-[[(5-methyl-2,1,3-benzothiadiazol-4-yl)amino]-sulfanylidenemethyl]benzamide
0
5-Methyl-2,1,3-benzothiadiazole
0
5-[5-(3-methoxybenzyl)-1,3,4-oxadiazol-2-yl]-2,1,3-benzothiadiazole
0
EG00229
0
N-(2,1,3-benzothiadiazol-4-yl)-3-(2-chloro-6-fluorophenyl)-5-methyl-4-isoxazolecarboxamide
0
N-(2,1,3-benzothiadiazol-4-yl)-5-(3-chlorophenyl)-2-furancarboxamide
0
N-(2,1,3-benzothiadiazol-5-yl)-2,4-dimethyl-6-oxo-3-pyrancarboxamide
0
N-[(2,1,3-benzothiadiazol-4-ylamino)-sulfanylidenemethyl]-4-methylbenzamide
0
N-[[(5-chloro-2,1,3-benzothiadiazol-4-yl)amino]-sulfanylidenemethyl]-2-furancarboxamide
0
Tizanidine hydrochloride
0
XL147
310
[1-(2,1,3-benzothiadiazol-4-ylsulfonyl)-3-piperidinyl]-(2-methyl-2,3-dihydroindol-1-yl)methanone
0
[1-(2,1,3-benzothiadiazol-5-ylmethyl)-4-(2-phenylethyl)-4-piperidinyl]methanol
0
acibenzolar +
0
acibenzolar-S-methyl
0
tizanidine
1
Path 2
CHEBI ontology
19874
subatomic particle
19872
composite particle
19872
hadron
19872
baryon
19872
nucleon
19872
atomic nucleus
19872
atom
19872
main group element atom
19811
p-block element atom
19811
carbon group element atom
19751
carbon atom
19748
organic molecular entity
19748
organic molecule
19700
organic cyclic compound
19490
organic heterocyclic compound
18868
organic heteropolycyclic compound
18294
organic heterobicyclic compound
17237
benzothiadiazole
311
(2S)-2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-2-phenyl-N-pyridin-4-ylacetamide
0
(2S)-2-[3-(aminomethyl)phenyl]-3-[(S)-\{(1R)-1-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-2-methylpropyl\}(hydroxy)phosphoryl]propanoic acid
0
1,2,3-benzothiadiazole-7-carboxylic acid
0
1-(1,3-benzodioxol-5-ylmethyl)-3-(2,1,3-benzothiadiazol-5-yl)thiourea
0
1-(2,1,3-benzothiadiazol-4-ylsulfonyl)-N-(6-methyl-1,3-benzothiazol-2-yl)-3-piperidinecarboxamide
0
4-methyl-N-[[(5-methyl-2,1,3-benzothiadiazol-4-yl)amino]-sulfanylidenemethyl]benzamide
0
5-Methyl-2,1,3-benzothiadiazole
0
5-[5-(3-methoxybenzyl)-1,3,4-oxadiazol-2-yl]-2,1,3-benzothiadiazole
0
EG00229
0
N-(2,1,3-benzothiadiazol-4-yl)-3-(2-chloro-6-fluorophenyl)-5-methyl-4-isoxazolecarboxamide
0
N-(2,1,3-benzothiadiazol-4-yl)-5-(3-chlorophenyl)-2-furancarboxamide
0
N-(2,1,3-benzothiadiazol-5-yl)-2,4-dimethyl-6-oxo-3-pyrancarboxamide
0
N-[(2,1,3-benzothiadiazol-4-ylamino)-sulfanylidenemethyl]-4-methylbenzamide
0
N-[[(5-chloro-2,1,3-benzothiadiazol-4-yl)amino]-sulfanylidenemethyl]-2-furancarboxamide
0
Tizanidine hydrochloride
0
XL147
310
[1-(2,1,3-benzothiadiazol-4-ylsulfonyl)-3-piperidinyl]-(2-methyl-2,3-dihydroindol-1-yl)methanone
0
[1-(2,1,3-benzothiadiazol-5-ylmethyl)-4-(2-phenylethyl)-4-piperidinyl]methanol
0
acibenzolar +
0
acibenzolar-S-methyl
0
tizanidine
1